Skip to main content
. 2009 Sep 21;27(31):5124–5130. doi: 10.1200/JCO.2009.22.0467

Fig 2.

Fig 2.

(A) Disease-free survival of 254 patients randomly assigned to preoperative or postoperative chemoradiotherapy, National Surgical Adjuvant Breast and Bowel Project R-03 (NSABP R-03) trial. (B) Overall survival of 254 patients randomly assigned to preoperative or postoperative chemoradiotherapy, NSABP R-03.